Mỹ Lành Vưu Thị

Mỹ Lành Vưu Thị

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 December 2025 in Bioengineering
Verified
Journal Article
Open access
PDF file
PLPhuc Truong Vinh Le
Phuc Truong Vinh Le
MNMitsuteru Nakamura
Mitsuteru Nakamura
MHMasakazu Higuchi
Masakazu Higuchi
MTMỹ Lành Vưu Thị
Mỹ Lành Vưu Thị
NHNhu Huynh
Nhu Huynh
STShinichi Tokuno
Shinichi Tokuno
Acoustic voice analysis demonstrates potential as a non-invasive biomarker for depression, yet its generalizability across languages remains underexplored. This cross-sectional study aimed to identify a set of cross-culturally consistent acoustic features for depression screening using distinct Vietnamese and Japanese voice datasets. We analyzed anonymized recordings from 251 participants, comprising 123 Vietnamese individuals assessed via the self-report Beck Depression Inventory (BDI) and 128 Japanese individuals assessed via the clinician-rated Hamilton Depression Rating Scale (HAM-D). From 6373 features extracted with openSMILE, a multi-stage selection pipeline identified 12 cross-cultural features, primarily from the auditory spectrum (AudSpec), Mel-Frequency Cepstral Coefficients (MFCCs), and logarithmic Harmonics-to-Noise Ratio (logHNR) domains. The cross-cultural model achieved a combined Area Under the Curve (AUC) of 0.934, with performance disparities observed between the Japanese (AUC = 0.993) and Vietnamese (AUC = 0.913) cohorts. This disparity may be attributed to dataset heterogeneity, including mismatched diagnostic tools and differing sample compositions (clinical vs. mixed community). Furthermore, the limited number of high-risk cases (n = 33) warrants cautious interpretation regarding the reliability of reported AUC values for severe depression classification. These findings suggest the presence of a core acoustic signature related to physiological psychomotor changes that may transcend linguistic boundaries. This study advances the exploration of global vocal biomarkers but underscores the need for prospective, standardized multilingual trials to overcome the limitations of secondary data analysis.

16 September 2026 in Discover Mental Health
Verified
Journal Article
Open access
PDF file
MBManh Xuan Bui
Manh Xuan Bui
LNLinh Tich Ngo
Linh Tich Ngo
NHNhu Huynh
Nhu Huynh
PLPhuc Truong Vinh Le
Phuc Truong Vinh Le
MTMỹ Lành Vưu Thị
Mỹ Lành Vưu Thị
PNPhong Duy Nguyen
Phong Duy Nguyen
Background Major Depressive Disorder (MDD) is linked to appetite and weight disturbances. While antidepressants (ADs) stabilize mood, their impact on psychological eating attitudes and behaviors remains underexplored. Objective This study aimed to investigate longitudinal changes in mean EAT-26 total and subscale scores (measuring disordered eating attitudes and behaviors) and to identify predictors over six months in Vietnamese MDD patients. Methods This single-center prospective cohort study at the University Medical Center Ho Chi Minh City enrolled 250 adult outpatients diagnosed with MDD who were initiating or continuing AD therapy. Participants were followed at baseline (T0), one month (T1), three months (T3), and six months (T6). Depressive symptoms were measured using the Quick Inventory of Depressive Symptomatology–Self-Report (QIDS-SR16), and eating attitudes and behaviors using the Eating Attitudes Test-26 (EAT-26). Multivariate associations were analyzed using generalized structural equation modeling (GSEM). Results At baseline, 32.3% of participants had severe or very severe depression (QIDS-SR16 > 15). Depressive symptoms improved significantly (45.2% remission at six months). However, the mean EAT‑26 total score increased substantially from 4.7 ± 5.1 at baseline to 17.0 ± 18.3 at six months (mean difference + 12.3, p < 0.001). All subscales—Dieting, Bulimia/Food Preoccupation, and Oral Control–showed significant progressive increases (p < 0.001). The prevalence of patients with EAT‑26 ≥ 20 increased from 1.6% at baseline to 39.6% at six months. “Increased Appetite/Weight Gain” was a strong predictors of higher EAT-26 scores (β = 3.2, p < 0.001), while clinical remission was associated with lower scores (β = − 6.1, p < 0.001). Conclusion The study identifies a divergence between mood improvement and the progressive worsening of mean EAT-26 scores during antidepressant treatment. Routine screening for disordered eating attitudes and behaviors – using continuous measures, not merely clinical cutoffs – is essential throughout depression treatment.